Kane Biotech Inc. (Tier2) (KNE)

Kane Biotech Inc. (Tier2) is related to 1 other symbol. To date we've encountered 3 releases involving Kane Biotech Inc. (Tier2).

Last Price: 0.09 (0.00) - 11/24/2008, 11:05am

• Open: 0.09
• High: 0.09
• Low: 0.09

Kane Biotech Inc. (Tier2) Options

• Kane Biotech Inc. (Tier2) "Business Partners"
• Kane Biotech Inc. (Tier2) Press Releases
• Kane Biotech Inc. (Tier2) News
• Kane Biotech Inc. (Tier2) Contact
• Kane Biotech Inc. (Tier2) Related (via TRYNT)

Kane Biotech Inc. (Tier2) "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Kane Biotech Inc. (Tier2).

• AFE

^

Kane Biotech Inc. (Tier2) Press Releases

• Kane Biotech Inc.: Kane Biotech Announces Positive Results From Central Venous Catheter Study (Trackbacks) (Backlinks), Mon, 16 Oct 2006 6:03:00 PDT

  WINNIPEG, MANITOBA (MARKET WIRE) Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent medical device related infections, is pleased to announce positive results from an important efficacy study with KBI-4258, its lead product for reducing infections associated with central venous catheters (CVCs).

• Kane Biotech Inc.: Kane Biotech Enters Study with KBI-4258 (Trackbacks) (Backlinks), Thu, 7 Sep 2006 6:03:00 PDT

  WINNIPEG, MANITOBA (MARKET WIRE)

• Kane Biotech Inc.: Kane Biotech Announces Amendment to Private Placement Offering (Trackbacks) (Backlinks), Wed, 10 May 2006 15:47:00 PDT

  WINNIPEG, MANITOBA (MARKET WIRE)

^

Kane Biotech Inc. (Tier2) News

• Kane Biotech Has Been Selected as One of Canada's Top 10(TM) Emerging Life Sciences Companies (CCNMatthews), Tue, 30 Sep 2008 13:38:22 Etc/GMT
• DispersinB(R) Trademark Registered in North America and Europe (CCNMatthews), Wed, 17 Sep 2008 13:23:19 Etc/GMT
• Clinical Grade DispersinB(TM) has Been Successfully Manufactured (CCNMatthews), Tue, 9 Sep 2008 13:25:35 Etc/GMT
• "The Economic Report" to Feature Kane Biotech Inc. (CCNMatthews), Tue, 2 Sep 2008 13:03:01 Etc/GMT
• Kane Biotech Enters into Material Transfer and Evaluation Agreement with Ward Industries Group (CCNMatthews), Tue, 22 Jul 2008 13:56:38 Etc/GMT
• Kane Biotech Meets Key Milestone in DispersinB(TM) Manufacturing Process (CCNMatthews), Mon, 7 Jul 2008 14:07:40 Etc/GMT
• A New Study Shows DispersinB(TM) Helps Our Body's Immune Cells to Kill Bacteria (CCNMatthews), Wed, 2 Jul 2008 14:33:34 Etc/GMT
• Kane Biotech Receives Notice of Allowance for DispersinB(TM) as a Registered Trademark (CCNMatthews), Wed, 25 Jun 2008 15:02:59 Etc/GMT
• Kane Biotech Retains BioVectra to Manufacture DispersinB(TM) (CCNMatthews), Tue, 4 Mar 2008 14:53:05 Etc/GMT
• Kane Biotech Announces the Closing of a $1,550,000 Private Placement (CCNMatthews), Thu, 28 Feb 2008 19:21:44 Etc/GMT
• Kane Biotech Announces Increase to Private Placement Offering (CCNMatthews), Wed, 20 Feb 2008 17:17:14 Etc/GMT
• Journal of Antimicrobial Chemotherapy Publishes Paper on Kane Biotech's PS/CHX Coating for Medical Devices (CCNMatthews), Wed, 13 Feb 2008 15:21:49 Etc/GMT
• Kane Biotech Announces Private Placement Offering (CCNMatthews), Tue, 12 Feb 2008 14:37:47 Etc/GMT
• Kane Biotech Awarded U.S. Patent for Compositions and Methods to Inhibit Biofilm Formation (CCNMatthews), Wed, 23 Jan 2008 14:26:07 Etc/GMT
• Kane Biotech Receives $405,000 Contribution From the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to Develop DispersinB(TM) Antibiofilm Wound Gel Product (CCNMatthews), Tue, 15 Jan 2008 13:30:24 Etc/GMT

^

Kane Biotech Inc. (Tier2) Contact

• Contacts:
  Kane Biotech Inc.
  Michael Coutts
  Director, Business Development
  (204) 477-7597
  (204) 453-1314 (FAX)
  info@kanebiotech.com
  www.kanebiotech.com
  
  

TRYNT Related

• Kane Biotech Inc. (Tier2) (KNE.V)

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.